🇺🇸 FDA
Patent

US 8921326

Sustained-release composition and method for producing the same

granted A61KA61K31/55A61K38/00

Quick answer

US patent 8921326 (Sustained-release composition and method for producing the same) held by Takeda Pharmaceutical Company Limited expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/55, A61K38/00, A61K38/08, A61K38/095